| Michael R Loewe, MD | |
|
5000 Hennessy Blvd, Our Lady Of The Lake Regional Medical Center, Baton Rouge, LA 70808-4375 | |
| (225) 765-7790 | |
| (630) 734-1560 |
| Full Name | Michael R Loewe |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 23 Years |
| Location | 5000 Hennessy Blvd, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811999428 | NPI | - | NPPES |
| 1042544 | Medicaid | LA | |
| P00254754 | Other | LA | RAILROAD MCARE THRU PEPA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 025632 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Our Lady Of The Lake Regional Medical Center | Baton rouge, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Professional Emergency Physician Associates, Llc | 1759317092 | 70 |
News Archive
Fulcrum Ventures announced today that they invested $1.25 million in Path-Tec, LLC. Founded in 2005, Path-Tec provides clinical, pharmaceutical and research labs with a turnkey solution for kit design, production, client supply management and patient specimen tracking.
Advocates today asked a single justice of the Massachusetts Supreme Judicial Court to declare the state's exclusion of thousands of legal immigrants from subsidized health coverage unconstitutional.
Injections of botulinum toxin A (botox) into the prostate are a promising alternative treatment for the millions of men who have benign prostatic hyperplasia (BPH), a condition commonly referred to as enlarged prostate, according to a study conducted by the University of Pittsburgh School of Medicine and Chang Gung Memorial Hospital in Taiwan.
Indian health experts say the findings of a US study — which suggest that population density is unrelated to COVID-19 infection rates — to be completely contradictory to their experience of dealing with the pandemic in India, a country with 1.3 billion people.
OxThera AB, a Stockholm-based privately-held biopharmaceutical company, today announced that it has initiated a clinical study in Primary Hyperoxaluria. This announcement bolsters the Company's position as a leader in developing therapies for hyperoxaluria, a debilitating condition that, if untreated, leads to kidney damage and end-stage renal disease.
› Verified 2 days ago
| Entity Name | Professional Emergency Physician Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992758247 PECOS PAC ID: 1759317092 Enrollment ID: O20050708000778 |
News Archive
Fulcrum Ventures announced today that they invested $1.25 million in Path-Tec, LLC. Founded in 2005, Path-Tec provides clinical, pharmaceutical and research labs with a turnkey solution for kit design, production, client supply management and patient specimen tracking.
Advocates today asked a single justice of the Massachusetts Supreme Judicial Court to declare the state's exclusion of thousands of legal immigrants from subsidized health coverage unconstitutional.
Injections of botulinum toxin A (botox) into the prostate are a promising alternative treatment for the millions of men who have benign prostatic hyperplasia (BPH), a condition commonly referred to as enlarged prostate, according to a study conducted by the University of Pittsburgh School of Medicine and Chang Gung Memorial Hospital in Taiwan.
Indian health experts say the findings of a US study — which suggest that population density is unrelated to COVID-19 infection rates — to be completely contradictory to their experience of dealing with the pandemic in India, a country with 1.3 billion people.
OxThera AB, a Stockholm-based privately-held biopharmaceutical company, today announced that it has initiated a clinical study in Primary Hyperoxaluria. This announcement bolsters the Company's position as a leader in developing therapies for hyperoxaluria, a debilitating condition that, if untreated, leads to kidney damage and end-stage renal disease.
› Verified 2 days ago
| Entity Name | Woman's Assessment Center Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205019908 PECOS PAC ID: 4789750829 Enrollment ID: O20080915000015 |
News Archive
Fulcrum Ventures announced today that they invested $1.25 million in Path-Tec, LLC. Founded in 2005, Path-Tec provides clinical, pharmaceutical and research labs with a turnkey solution for kit design, production, client supply management and patient specimen tracking.
Advocates today asked a single justice of the Massachusetts Supreme Judicial Court to declare the state's exclusion of thousands of legal immigrants from subsidized health coverage unconstitutional.
Injections of botulinum toxin A (botox) into the prostate are a promising alternative treatment for the millions of men who have benign prostatic hyperplasia (BPH), a condition commonly referred to as enlarged prostate, according to a study conducted by the University of Pittsburgh School of Medicine and Chang Gung Memorial Hospital in Taiwan.
Indian health experts say the findings of a US study — which suggest that population density is unrelated to COVID-19 infection rates — to be completely contradictory to their experience of dealing with the pandemic in India, a country with 1.3 billion people.
OxThera AB, a Stockholm-based privately-held biopharmaceutical company, today announced that it has initiated a clinical study in Primary Hyperoxaluria. This announcement bolsters the Company's position as a leader in developing therapies for hyperoxaluria, a debilitating condition that, if untreated, leads to kidney damage and end-stage renal disease.
› Verified 2 days ago
| Entity Name | Ascension Emergency Physicians, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699118505 PECOS PAC ID: 9739320029 Enrollment ID: O20130730000082 |
News Archive
Fulcrum Ventures announced today that they invested $1.25 million in Path-Tec, LLC. Founded in 2005, Path-Tec provides clinical, pharmaceutical and research labs with a turnkey solution for kit design, production, client supply management and patient specimen tracking.
Advocates today asked a single justice of the Massachusetts Supreme Judicial Court to declare the state's exclusion of thousands of legal immigrants from subsidized health coverage unconstitutional.
Injections of botulinum toxin A (botox) into the prostate are a promising alternative treatment for the millions of men who have benign prostatic hyperplasia (BPH), a condition commonly referred to as enlarged prostate, according to a study conducted by the University of Pittsburgh School of Medicine and Chang Gung Memorial Hospital in Taiwan.
Indian health experts say the findings of a US study — which suggest that population density is unrelated to COVID-19 infection rates — to be completely contradictory to their experience of dealing with the pandemic in India, a country with 1.3 billion people.
OxThera AB, a Stockholm-based privately-held biopharmaceutical company, today announced that it has initiated a clinical study in Primary Hyperoxaluria. This announcement bolsters the Company's position as a leader in developing therapies for hyperoxaluria, a debilitating condition that, if untreated, leads to kidney damage and end-stage renal disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael R Loewe, MD Po Box 95020, Professional Emergency Physician Associates Llc, New Orleans, LA 70195-5020 Ph: (630) 734-0200 | Michael R Loewe, MD 5000 Hennessy Blvd, Our Lady Of The Lake Regional Medical Center, Baton Rouge, LA 70808-4375 Ph: (225) 765-7790 |
News Archive
Fulcrum Ventures announced today that they invested $1.25 million in Path-Tec, LLC. Founded in 2005, Path-Tec provides clinical, pharmaceutical and research labs with a turnkey solution for kit design, production, client supply management and patient specimen tracking.
Advocates today asked a single justice of the Massachusetts Supreme Judicial Court to declare the state's exclusion of thousands of legal immigrants from subsidized health coverage unconstitutional.
Injections of botulinum toxin A (botox) into the prostate are a promising alternative treatment for the millions of men who have benign prostatic hyperplasia (BPH), a condition commonly referred to as enlarged prostate, according to a study conducted by the University of Pittsburgh School of Medicine and Chang Gung Memorial Hospital in Taiwan.
Indian health experts say the findings of a US study — which suggest that population density is unrelated to COVID-19 infection rates — to be completely contradictory to their experience of dealing with the pandemic in India, a country with 1.3 billion people.
OxThera AB, a Stockholm-based privately-held biopharmaceutical company, today announced that it has initiated a clinical study in Primary Hyperoxaluria. This announcement bolsters the Company's position as a leader in developing therapies for hyperoxaluria, a debilitating condition that, if untreated, leads to kidney damage and end-stage renal disease.
› Verified 2 days ago
Dr. Wame Nicholas Waggenspack Jr., M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 8080 Bluebonnet Blvd, Suite 1000, Baton Rouge, LA 70810 Phone: 225-924-2424 Fax: 225-408-7984 | |
Terence James Alost, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 7777 Hennessy Blvd, Suite 211, Baton Rouge, LA 70808 Phone: 225-765-7163 | |
Tiffany Le'shann Dugas, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 5246 Brittany Dr, Baton Rouge, LA 70808 Phone: 225-387-7736 | |
Timothy Brandon Davidson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3317 Grand Way Ave, Baton Rouge, LA 70810 Phone: 225-400-3542 | |
Alyssa Victoria Gonzales, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5246 Brittany Dr, Baton Rouge, LA 70808 Phone: 225-757-4142 | |
Dr. Timothy A Girard, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3600 Florida Blvd, Baton Rouge, LA 70806 Phone: 225-387-7053 | |
Pamela Payment, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3600 Florida Blvd, Baton Rouge, LA 70806 Phone: 225-387-7053 |